Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Kadimastem Holds Successful Preliminary Meeting with the FDA (INTERACT) Regarding IsletRx for the Treatment of Diabetes

Kadimastem

Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing cell therapy treatments for ALS and diabetes, announced today that the Company held a preliminary meeting with the FDA (INTERACT) on October 7, 2021 regarding IsletRx, the company’s cell therapy product in development for the treatment of diabetes. During the meeting, Kadimastem received a response document from the FDA noting that the company’s clinical development plan for IsletRx was being positively considered. It also included constructive comments and guidelines applicable for the next step pre-IND submission. This interaction is of great importance to Kadimastem’s clinical product development process and is an important milestone for the company. It was Kadimastem’s first meeting with the FDA regarding its diabetes project and the FDA’s first review of IsletRx, which demonstrated positive results in preclinical trials. IsletRx is an expanded population of allogeneic stem cells differentiated into functioning insulin producing pancreatic islet cells. The company then uses a proprietary technology to select the purest performing cells from its population and puts them into a microcapsule that protects the cells from being rejected by the body’s immune system. The implanted cells have shown in preclinical studies to be able to detect the sugar levels in the body and to, produce, and secrete, on demand, the required amounts of insulin and glucagon, just like a healthy pancreas. Kadimastem CEO Asaf Shiloni said, "Thanks to Dr. Kfir Molakandov, the Director of Diabetes at Kadimastem, who presented the IsletRx project in an impressive manner, we received a positive response to the company’s clinical development outline from the FDA's expert team, who we believe were overall very impressed with our technology. The FDA’s expert team provided us with important feedback that we will use to prepare for the next step, our Pre-IND submission for IsletRx. I am convinced that the successful meeting and the relevant feedback will contribute to the continued progress of our product development and if all goes well, ultimately provide a cure for those living with diabetes.” Kadimastem Chief Scientist Professor Michel Revel said, “The INTERACT meeting with the FDA is an important step forward and shows that Kadimastem's development plan for its diabetes treatment product, IsletRx, is in the right direction.” About Kadimastem: Kadimastem is a clinical stage cell therapy company, developing and manufacturing "off-the-shelf", allogeneic, proprietary cell products based on its technology platform for the expansion and differentiation of Human Embryonic Stem Cells (hESCs) into functional cells. AstroRx®, the company's lead product, is an astrocyte cell therapy in clinical development as a treatment for ALS. IsletRx is the company's second product in development. IsletRx is comprised of functional pancreatic islet cells intended to cure patients with insulin dependent diabetes. IsletRx demonstrated safety and efficacy in a proof-of-concept preclinical study. An INTERACT meeting took place with the FDA on October 7, 2021 where the diabetes treatment program was discussed and the company received directions how to prepare its Pre-IND submission. Kadimastem was founded by Professor Michel Revel, CSO of the company and Professor Emeritus of Molecular Genetics at the Weizmann Institute of Science. Professor Revel received the Israel Prize for the invention and development of Rebif®, a multiple sclerosis blockbuster drug sold worldwide. Kadimastem is traded on the Tel Aviv Stock Exchange (TASE: KDST). Forward Looking Statement: This document may include forward-looking information as defined in the Securities Law, 5728 – 1968. Forward-looking information is uncertain and mostly is not under the Company's control and the realization or non-realization of forward-looking information will be affected, among other things, by the risk factors characterizing the Company's activity, as well as developments in the general environment and external factors affecting the Company's activity. The Company's results and achievements in the future may differ materially from any presented herein and the Company makes no undertaking to update or revise such projection or estimate and does not undertake to update this document. This document does not constitute a proposal to purchase the Company's securities or an invitation to receive such offers. Investment in securities in general and in the Company in particular bears risks. One should consider that past performance does not necessarily indicate performance in the future. Contact Details Must Have Communications Marjie Hadad marjie@mhc-pr.com Kadimastem Sarah Herzl +972 73-797-1613 s.herzl@kadimastem.com Company Website https://www.kadimastem.com/

October 12, 2021 09:54 AM Eastern Daylight Time

US Digestive Health Announces Pilot with AI-Enhanced Endoscopy Aid Device, GI Genius

US Digestive Health

US Digestive Health, a management services organization created to expand access to high-quality, value-based gastroenterology care, began a trial with GI Genius, a state-of-the-art AI-enhanced endoscopy aid device for the detection of colorectal lesions during colonoscopy. GI Genius utilizes artificial intelligence to improve detection of colorectal cancer during screening colonoscopy procedures. Medtronic received approval from the FDA in April of this year. US Digestive Health initiated a trial of the new technology in July 2021 and is the first practice in Pennsylvania to offer GI Genius. “We are constantly researching and investing in ways to help our providers detect potentially cancerous lesions,” said Dr. Dale Whitebloom, Chief Medical Officer of US Digestive Health. “We want the very best for our patients and if AI helps us to detect cancerous and precancerous lesions more effectively then we want to explore it thoroughly.” GI Genius is a combination of hardware and software that helps identify regions of interest during the colonoscopy. The device is not intended to replace lab sampling or suggest a course of action to the physician – but it does aid in highlighting areas of concern for providers to address. “US Digestive Health is committed to bringing the latest advances in colorectal cancer screening to our communities,” said Jerry Tillinger, CEO of US Digestive Health. “We are proud to be the first practice in Pennsylvania to deploy this incredible technology for our patients.” With offices throughout Central and Southeastern Pennsylvania, including the Greater Philadelphia region, US Digestive Health works hand-in-hand with gastroenterology partner practices to meet the challenges of a fast-changing healthcare landscape. By providing innovative business management and technology solutions that ease administrative burdens and support their financial success, US Digestive Health allows physicians to stay focused on delivering great patient care. US Digestive Health was formed in 2019 by Amulet Capital Partners, LP (“Amulet”), a healthcare private equity investment firm based in Greenwich, Connecticut, in partnership with member practice partner physicians. For more information, visit https://usdigestivehealth.com/ About US Digestive Health As the leading gastroenterology practice on the East Coast, US Digestive Health is at the forefront of the rapidly advancing science of digestive health, bringing new insight into the care, treatment and prevention of digestive health disorders. For more information, visit https://usdigestivehealth.com. About Amulet Capital Partners, LP Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million. For additional information, please visit www.amuletcapital.com. Media Contact for Amulet Capital Partners, LP Melissa Sheer Kent Place Communications, LLC 917-690-2199 melissa@kentplacellc.com Contact Details Noah Ramagano nramagano@usdhealth.com Company Website https://usdigestivehealth.com

October 12, 2021 07:56 AM Eastern Daylight Time

MOTIS Brands Acquires Mac’s Custom Tie-Downs

Rotunda Capital Partners LLC

MOTIS Brands (“MOTIS”), a Rotunda Capital Partners portfolio company, has acquired Mac’s Custom Tie-Downs (“Mac’s”), a leading manufacturer of high-quality tie-down systems for trailers and truck beds. For nearly 30 years, Mac’s has been innovating and producing tie-down solutions from their headquarters in Sagle, Idaho. The acquisition of Mac’s adds another premium brand to MOTIS’s portfolio of loading, hauling, automotive, and accessibility brands, and further strengthens its position as a leader in truck and trailer cargo control. “We are excited to add Mac’s line of outstanding products and their talented team to the MOTIS family of brands,” said MOTIS CEO Rich Spratt. “Mac’s adds additional U.S. manufacturing capabilities and another strong brand to our assortment. Our goal remains to assemble the broadest and deepest collection of premium products for loading, hauling, storage and productivity needs, and Mac’s is an ideal addition to our offering.” About MOTIS Brands Headquartered in Germantown, WI, MOTIS Brands proudly designs, develops, and distributes a collection of industry leading loading, hauling, automotive and accessibility brands including Race Ramps®, Silver Spring Mobility®, Heavy Duty Ramps™, Black Widow®, Guardian Industrial Products™, Kill Shot®, Tilt-a-Rack®, Harbor-Mate®, Lucky Dog™, Big Boy®, and Mac’s Custom Tie-Downs. For more information, visit www.motisbrands.com. About Rotunda Capital Partners Rotunda Capital Partners is a private equity firm that invests equity capital in established, lower middle market companies. Rotunda partners with management to build data-driven growth platforms within its targeted sectors, including value-added distribution, asset light logistics and industrial/business services. Founded in 2009, the firm has a long history of helping management teams achieve their goals for growth. The Rotunda team actively provides guidance and draws on deep industry and financial relationships to contribute to the successful execution of Rotunda’s companies’ strategic plans. The firm has offices in Bethesda, MD and Evanston, IL. For more information, visit www.rotundacapital.com. Contact Details Jill Lafferty +1 847-280-1295 jill@rotundacapital.com Company Website https://www.rotundacapital.com

October 12, 2021 07:34 AM Eastern Daylight Time

Harrods enters the limited-edition sneaker market welcoming The Edit LDN

Stockwood Strategy

The UK’s leading online store for limited edition sneakers and high-end streetwear The Edit LDN, today announced the opening of its first ever UK boutique store in Harrods, one of London’s most famous department stores. Harrods visitors will be able to see, experience and buy the latest limited-edition sneakers from The Edit LDN. Already popular with royalty, celebrities and footballers, The Edit LDN is a leading online destination that sells the hottest and hardest to get sneakers and streetwear from brands including Yeezy, Jordan, Off-White and collaborations through to Supreme, among others to a wide community of fashionistas, collectors and investors. Just as premium sites like Farfetch address the fashion world, The Edit LDN showcases the latest sneakers and high-end streetwear. They connect premium resellers with a highly engaged, price agnostic and eager audience. Moses Rashid, Founder and CEO of The Edit LDN commented: “We want to expand and increase accessibility for people who want to own limited edition sneakers around the world. Being the first sneaker reseller in Harrods is a proud and milestone moment for the company and its great to see such a global mega brand engaging with the sneaker market, moreover, that we're the catalyst to make that happen. Harrods offers an amazing customer journey to their global customer base and this aligns completely with our approach, to offer the best in class service. In 18 months, we have expanded our community of buyers from avid sneaker fans to TV and film celebrities as well as professional footballers and royal families around the world. Opening in Harrods is a logical next step as we bring our unique proposition to their customer base”. The Edit LDN has established itself as a trusted source of authenticated and high quality new and pre-loved streetwear and sneakers. Their unabating focus on speed (to deliver purchased goods), customer service engagement and ensuring all goods are authenticated has been testament to the growth of the platform and community. Simon Longland, Head of Menswear at Harrods commented: “Over the past three years, menswear at Harrods has undertaken a huge transformation, that has been visible through our brand curation as well as the physical shop floor. Our goal has been to transform the menswear experience at Harrods and embrace the most important and desirable trends on the market, and the launch of The Edit LDN continues that strategy. Bringing The Edit LDN’s industry expertise to Harrods ensures that our customers have access to the latest and most exclusive styles on the market through a service level which is unmistakably Harrods.” Helen David, Chief Merchant at Kurt Geiger added: “We’ve been at the forefront of embracing the latest trends serving a wide and diverse range of customers. What used to be considered sportswear is now considered luxury, and the shoes that are the most wanted and the hottest tickets are now sneakers. Without this as part of our matrix at Harrods, we wouldn’t have a proper 360 luxury offer. Hosting The Edit LDN at Harrods is testament to our commitment of meeting our customer needs with the market-leader in the premium sneaker business. Our shared objective with The Edit LDN is to ensure that Harrods’ customers have access to the latest and best on the market to meet their lifestyle needs.” Looking ahead, Moses said: “This is a marketplace worth $6b a year globally and will grow 5x by 2030. The demand for sneakers is growing every day and we are at the heart of servicing this trend. It’s been a remarkable 18 months since we launched to now opening in Harrods, the world’s most iconic department store. We are in hyper growth and headed in the right trajectory as we scale the business globally. Our on-going funding round will enable us to move faster and achieve our goals“. About The Edit LDN Founded in 2020, The Edit LDN has quickly become the UK’s leading online consignment store for limited edition sneakers and high end streetwear, both new and pre-loved items. Their innovative platform connects premium resellers to a global audience offering a deluxe experience from discovery, packaging and delivery. Brands include Jordan, Yeezy, Louis Vuitton, Dior, Off-White, Supreme, Fear of God among others. The platform is fast becoming synonymous with speed of service, authenticity, diverse selection of secure payment methods, and first class customer service. The Edit LDN is the leading destination for resellers and their premium sneakers and streetwear. Through partnerships with styling services such as Thread.com and various concierge companies, The Edit LDN has a community of buyers celebrities to professional footballers and royal families around the world. Further information visit: www.theeditldn.com. You are welcome to follow us on LinkedIn, Facebook or Instagram About Harrods Harrods began as a wholesale grocer and tea merchant in east London, first opening its doors in 1834. Since then, it has grown to become the world’s most famous department store, known for its unrivalled range of luxury merchandise. As well as exclusive brands and myriad departments, one of Harrods’ most renowned attributes is its unparalleled service. Harrods continues to be guided by its philosophy of “anything is possible” and, to this day, our customers remain at the heart of everything we do. Harrods.com About Kurt Geiger Kurt Geiger is a premium footwear brand operating across the UK. It first opened its doors on Bond Street in 1963. Kurt Geiger's own brands for women, men and children include Kurt Geiger London, KG, Carvela and Miss KG. Kurt Geiger has operated the Harrods and Selfridges footwear departments for the past 25 years. This unique positioning sets Kurt Geiger apart as a distinctive and unparalleled multi-channel business selling third-party and owned brands through department store concessions. The brand has over 80 stores worldwide, kurtgeiger.com, as well as e-commerce concession sites and wholesale partners. Selling over four million pairs of shoes a year this makes Kurt Geiger the largest luxury footwear retailer in Europe. Contact Details The Edit LDN Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.theeditldn.com/

October 11, 2021 09:00 AM Eastern Daylight Time

Image

News Release

Creating Buzz PR Announces ‘Be Your Own Publicist‘ Class For Entrepreneurs & Small Business Owners

Creating Buzz PR

Creating Buzz PR, one of California and Arizona’s most creative and respected public relations firms, will offer publicity classes for small business owners that typically could not afford the prices of a respected PR firm. Ellie Lowney, founder of Creating Buzz PR, has catapulted companies such as Superstition Meadery and Personality Hotels from small start ups to thriving mid size business’s through her creative campaigns. Called ‘Catapult Your Brand With Publicity’, this class will teach entrepreneurs all they need to know to get coverage in respected media outlets such as USA Today, Entrepreneur.com, CNN, Forbes, Local and real (unpaid) TV coverage, local and real print and digital News outlets, INC.com, and much more. “I want to help even the playing field for small business owners” states Ellie. “They are the backbone of America and so many have great ideas and intentions but fail in the first year or two, which is sad.” According to statistics published in 2019 by the Small Business Administration (SBA), about twenty percent of business startups fail in the first year. About half succumb to business failure within five years. By year ten, only about 33% survive. “I know one of the main reasons entrepreneurs fail is because they don’t put enough time, energy, and money into promoting the business”, states Ellie. “I have seen it with friends and potential clients. There is often an attitude of “if I build it - they will come,” so they put tons of money into interior design, or a quality product, and website, but then don’t have enough money left for marketing.” Quality PR firms, including Creating Buzz PR, charge $150.00 to $500.00 and up - per hour, with a minimum of $3000.00 per month, and many small business owners can not afford that. “To hire a good PR pro is expensive because it is time consuming to do it right and requires a talented person who can wear many hats including research to create the right campaign and brand, writing great stories, pitching the media (sales), being a sleuth to find those perfect journalists, etc”. “It is not for the faint of heart. Companies should know it is like hiring your content creation team, sales team, business coach, idea person, project manager, connector, and more in one or two people.” Being a small business owner herself and having many friends that are entrepreneurs, Ellie saw the need for classes for startups, that have more time than money, to put into promotion. “Entrepreneurs should always be thinking of promoting and how they can gain credibility and interest from their target market before they even start the business” states Ellie. The first three classes of the six week course will cover how to write a compelling story and make it newsworthy, finding the right journalists and media outlets, writing press releases, media alerts, and pitches, and - most importantly - how to pitch the media. The second half of the course will cover newswires, such as News Direct and Cision, plus social media, business building events, media stunts, and more. The classes will be interactive through Zoom and will be kept to a small group, so all attendees can ask questions and get personalized help. Additionally there are specific class’s for health and aesthetic practice publicity and hospitality and restaurant publicity. “I so believe in publicity in respected media outlets and what it can do for a brand,” states Ellie. I have seen it happen with my clients, where they see their sales triple, then skyrocket, in a few short months from great press, or see their business launched from just one event.” About Creating Buzz PR and Ellie Lowney Ellie is a writer and senior communications specialist with twenty years experience in PR and marketing. Ellie has led campaigns for companies and brands such as The Fairmont Hotel, Core Institute, Superstition Meadery, WorldWildlife Fund, Pacific Autism Centers, Personality Hotels, Biogenesis Nutraceuticals, and many more. She started in PR in San Francisco and started Creating Buzz PR in 2017. Creating Buzz PR, 4232 N 32nd Street, Phoenix, AZ., 85018 www.creatingbuzzpr.com https://creatingbuzzpr.com/catapult-your-brand-2/ About Creating Buzz PR and Ellie Lowney Ellie is a writer and senior communications specialist with twenty years experience in PR and marketing. Ellie has led campaigns for companies and brands such as The Fairmont Hotel, Core Institute, Superstition Meadery, WorldWildlife Fund, Pacific Autism Centers, Personality Hotels, Biogenesis Nutraceuticals, and many more. She started in PR in San Francisco and started Creating Buzz PR in 2017. Creating Buzz PR, 4232 N 32nd Street, Phoenix, AZ., 85018 https://www.creatingbuzzpr.com https://creatingbuzzpr.com/catapult-your-brand-2/ Contact Details Creating Buzz PR Ellie +1 415-948-5275 Elizabeth@CreatingBuzzPR.com Company Website https://www.creatingbuzzpr.com

October 07, 2021 06:00 AM Eastern Daylight Time

GRYT Health to Host Third Annual Global Virtual Cancer Conference (GVCC) in November

GRYT Health

GRYT (“grit”) Health, a digital oncology company that empowers people to be in charge of their own health, is hosting the third annual Global Virtual Cancer Conference (GVCC) from November 11–13, 2021. GVCC is the original digital cancer conference created by and for survivors and caregivers. GVCC21 will address topics critical to improving cancer-related outcomes and experiences, focusing on empowering those impacted by cancer through connection, education, and advocacy. “As an oncology researcher and a two-time cancer survivor, GVCC makes my mind and my heart proud,” said Dave Craig, co-founder and chief executive officer of GRYT Health. “Our mission is to improve quality of life and increase survival for people facing cancer through the relentless focus on patient experience. We’re proud to partner with healthcare organizations who are working towards this same goal by elevating the patient voice and collectively bringing the GVCC experience to patients and caregivers wherever they are.” Conference highlights include: Sessions ranging on issues important to those experiencing cancer, including becoming an advocate, patient/provider communication, navigating clinical trials, metastatic cancer, dealing with long-term side effects, integrative healthcare, health equity and diversity, relationships and cancer, and a live “Finding Power Through Your Voice” Event where community members get a chance to share their stories live during the conference More than 50 participating organizations who will share resources to navigate treatment and survivorship, as well as information on cancer research projects actively recruiting Ample time for connection with peers and fun, including a guided relaxation meditation, an art therapy class, yoga, and a live comedic magician In its first two years, GVCC has brought together more than 5,000 individuals from nearly 50 countries, close to 200 speakers, and more than 100 non-profit patient advocacy organizations to participate in courageous conversations on the quest for cures. “Now in its third year, GVCC21 continues its legacy of helping those affected by cancer find their voice and find a community,” said Cathy Trzaskawka, executive director, patient advocacy at Bristol Myers Squibb. “We’re proud to partner with GRYT Health on this important program as part of our continued commitment to patients worldwide, helping to connect and support the cancer community.” GVCC21 is hosted on GRYT Health’s proprietary virtual technology platform that encourages interaction. The system leverages Zoom meeting functionality for presentations, performances and breakouts. Registration for GVCC21 is free and available to all at https://globalvirtualcancerconference.com/. The Founding Partner for GVCC21 is Bristol Myers Squibb. Sponsors of the event include Amgen, EMD Serono, Takeda, Deep Lens, Syneos Health, Seagen and CURE Media Group. Partners include 2for2Boobs, A Ballsy Sense of Tumor, Abridge, Ancora.ai, Aplastic Anemia and MDS International Foundation, ASCP Patient Champions, b Present Foundation, Bag It, Breast Advocate, Brilliantly, Cactus Cancer Society, CancerCare, Cassie Hines Shoes Cancer Foundation, Cervivor, Colon Cancer Coalition, DeipC Foundation, Dear Jack Foundation, Elephants &Tea, Epic Experience, Escape, European Cancer Patient Coalition, Family Reach, First Descents, Global Colon Cancer Association, Health Central, Lung Cancer Initiative, Imerman Angels, IWMF, Keep A Breast, LUNGevity, MDS Foundation, Next Step, PAN Foundation, Patient Power, Hope for Stomach Cancer, Stupid Cancer, The Leukemia & Lymphoma Society, The Patient Story, The White Ribbon Project, ThyCa: Thyroid Cancer Survivors’ Association, Inc., Tigerlily Foundation, Triage Cancer, World Bladder Cancer, Young Adult Survivors United, and Young Survival Coalition. GRYT Health is a digital oncology company that empowers people to be in charge of their own health through education, engagement and support. We offer a community free from judgment that focuses on humanity and the value each person brings. Our mission is to improve quality of life and increase survival for people facing cancer through the relentless focus on patient experience. We put patients first and work with healthcare organizations that do the same. We use the patient voice to enhance drug development and access; and together, we are helping to move healthcare forward. Visit www.grythealth.com to learn more. Contact Details Nick Gardner +1 917-828-7119 Nick.Gardner@evokegroup.com Company Website https://www.grythealth.com

October 06, 2021 09:06 AM Eastern Daylight Time

ADDING MULTIMEDIA: FINE HYGIENIC HOLDING ENTERS THE METAVERSE WITH LAUNCH OF FINE ICONIC PACK NFT

Fine Hygienic Holding

Fine Hygienic Holding (FHH), the leading wellness group and manufacturer of reusable protective masks and hygienic paper products, has created its first ever NFT (Non-Fungible Token) collectible, an animated digital art piece has gone live for open auction on OpenSea, the marketplace for rare digital items and crypto collectibles, from September 26 until October 14. The Fine Iconic Pack collectible, which will be available to the highest bidder, will include a 17-second digital animated file of the iconic brand plus a physical gold-plated Fine Facial Tissue holder as unlockable content. The digital animated file showcases the transformation of the iconic Fine branding, a much-loved logo familiar to households across the region for over 60 years. FHH CEO James Michael Lafferty said: “Fine Hygienic Holding is a brand of the future, we are not afraid to embrace change as customers will already know through our move into reusable Fine Guard face masks, and other products including hand sanitizers and wipes which incorporate innovative technology. “The launch of the NFT underlines our credentials as a brand of the future. We are confident that there are many potential buyers out there in the region who would be interested in a digital collectible that evokes a sense of nostalgia and heritage, while also showcasing the progress and growth of the business and the virtual world.” The sole owner of the NFT will be granted a royalty-free license to use, copy and display the NFT for personal, non-commercial use, as well as the right to resale the NFT as a digital file. For more information on FHH's NFT auction, visit: https://opensea.io/assets/0x495f947276749ce646f68ac8c248420045cb7b5e/44489654802199576746768233299675622972679876205981352264859019804128938295297/ About Fine Hygienic Holding: Fine Hygienic Holding (FHH), one of the world’s leading wellness groups and the MENA’s leading manufacturer of hygienic products, serves consumers in more than 80 countries around the world. Originally established as a paper manufacturer, FHH has transformed into a wellness company dedicated to enhancing global health and wellbeing. With its commitment to becoming “the shining star of the Arab FMCG business world,” the Group focuses on wellness, sustainability, state-of-the-art production processes, pioneering CSR programs, and award-winning products. The company offers a diverse array of products including sterilized facial tissues, napkins, kitchen towels, toilet paper, baby diapers, adult briefs, jumbo rolls, as well as away-from-home products to accommodate all types of private and public institutions, in addition to innovative personal protective equipment (PPE), long lasting germ protection solutions and natural nutritional supplements. Contact Details Salma Khalifa +971 55 554 1994 salma.k@actionprgroup.com Company Website https://www.finehh.com/

October 06, 2021 07:22 AM Eastern Daylight Time

Video

FINE HYGIENIC HOLDING BECOMES FIRST MIDDLE EAST-BASED FMCG COMPANY TO ENTER THE METAVERSE WITH LAUNCH OF FINE ICONIC PACK NFT

Fine Hygienic Holding

Fine Hygienic Holding (FHH), the leading wellness group and manufacturer of reusable protective masks and hygienic paper products, has become the first Middle East-based FMCG company to create its own NFT (Non-Fungible Token) collectible. The Fine Iconic Pack collectible, an animated digital art piece, has gone live for open auction on OpenSea, the marketplace for rare digital items and crypto collectibles, for a limited time only, from September 26 until October 14. The collectible, which will be available to the highest bidder, will include a 17-second digital animated file of the iconic brand plus a physical gold-plated Fine Facial Tissue holder as unlockable content. The digital animated file showcases the transformation of the iconic Fine branding, a much-loved logo familiar to households across the region for over 60 years. FHH CEO James Michael Lafferty said: “Fine Hygienic Holding is a brand of the future, we are not afraid to embrace change as customers will already know through our move into reusable Fine Guard face masks, and other products including hand sanitizers and wipes which incorporate innovative technology. “The launch of the NFT underlines our credentials as a brand of the future. We are confident that there are many potential buyers out there in the region who would be interested in a digital collectible that evokes a sense of nostalgia and heritage, while also showcasing the progress and growth of the business and the virtual world.” The sole owner of the NFT will be granted a royalty-free license to use, copy and display the NFT for personal, non-commercial use, as well as the right to resale the NFT as a digital file. For more information on FHH’s NFT auction, visit: https://opensea.io/assets/0x495f947276749ce646f68ac8c248420045cb7b5e/44489654802199576746768233299675622972679876205981352264859019804128938295297/ About Fine Hygienic Holding:Fine Hygienic Holding (FHH), one of the world’s leading wellness groups and the MENA’s leading manufacturer of hygienic products, serves consumers in more than 80 countries around the world. Originally established as a paper manufacturer, FHH has transformed into a wellness company dedicated to enhancing global health and wellbeing. With its commitment to becoming “the shining star of the Arab FMCG business world,” the Group focuses on wellness, sustainability, state-of-the-art production processes, pioneering CSR programs, and award-winning products. The company offers a diverse array of products including sterilized facial tissues, napkins, kitchen towels, toilet paper, baby diapers, adult briefs, jumbo rolls, as well as away-from-home products to accommodate all types of private and public institutions, in addition to innovative personal protective equipment (PPE), long lasting germ protection solutions and natural nutritional supplements. Contact Details Action PR Salma Khalifa +971 55 554 1994 salma.k@actionprgroup.com Company Website https://www.finehh.com/

October 06, 2021 02:20 AM Eastern Daylight Time

National Poll Shows Public Trust in Big Tech is Falling Fast

Public Affairs Council

A new Public Affairs Council/Morning Consult poll finds the pharmaceutical industry has remained the least-trusted sector in American business — despite supplying life-saving COVID-19 vaccines for hundreds of millions of people. It has now ranked last of nine sectors for five straight years. But the sector with the sharpest drop in trust over the past five years is the technology industry, which has seen its trust ranking slip from first place to sixth place. The annual Public Affairs Pulse survey of 2,199 adults, conducted Sept. 2-6, 2021, explores the intersection of business, government and society. In addition to the trust deficit, this year’s poll examines racism in America, reliable sources of political news, the most highly valued democratic principles, and who should take the lead on vaccine mandates. Business sector trust rankings Technology, considered the most trustworthy sector in the U.S. as recently as 2017, has dropped to sixth place out of nine industries rated. Thirty-two percent (32%) now consider the tech sector to be less trustworthy than other industries. Forty-six percent (46%) of the public say pharmaceutical companies are less trustworthy than other major companies. Only 13% believe they are more trustworthy. The pharmaceutical sector is also considered the most under-regulated industry, with 40% saying it has too little regulation. The health insurance industry is the next lowest-ranking sector, with 41% calling it less trustworthy than other industries. It is right behind pharmaceuticals on the list of the most under-regulated sectors. The public has the most trust in the Food & Beverage sector with just 14% saying it is less trustworthy than other industries and 21% saying it is more trustworthy. “These low-trust rankings remind me of the old saying, ‘No good deed goes unpunished,’” said Public Affairs Council President Doug Pinkham. “Despite the efforts of the pharmaceutical and health insurance industries to protect the public from the pandemic, and though their scores did improve over last year, deep-rooted distrust is slow to change.” Are Democrats becoming more pro-business? While 51% of Democrats trust political information they receive from major companies, only 44% of Republicans trust political information from Corporate America. When it comes to promoting COVID-19 vaccinations, 78% of Democrats support corporate efforts but only 42% of Republicans support such efforts. While 65% of Democrats approve when the business community speaks out against racism, only 28% of Republicans favor those actions. Racism is getting worse, and companies aren’t making a major impact Despite growing support for Black Lives Matter and changes in corporate diversity practices, 40% of Americans believe the U.S. is becoming more racist. Only 13% think it is becoming less racist. Seventy-one percent (71%) of Americans consider racism a somewhat or very serious problem. Only 8% believe racism is not at all serious. While Democrats are more likely to be pessimistic about racism, more than twice as many Republicans (33%) believe racism is getting worse than believe it is getting better (15%). Just 22% of the public say major companies are playing a positive role in reducing racism (down from 28% last year), and 18% say they are playing a negative role (up from 14%). Strong majority of Americans support free and fair elections When asked about the value of actions to promote democratic rights, Americans give the highest ratings to support of free and fair elections (74%) and freedom of speech (72%). Just 59% believe protecting freedom of the press is very important to the country. The strongest support for freedom of the press comes from Americans aged 65 and older. Among 18-34-year-olds, however, only 50% consider protecting freedom of the press to be very important. Just 26% of Americans say Congress is doing a good or excellent job of supporting democracy compared to 41% who say the same about President Biden. People trust “friends and family” for political news For 73% of the public, friends and family are the most trusted source of political news. The next most trusted sources are trade and professional associations (44%) and businesses (43%). Only 41% trust the news media for political information, and more than half of Americans (52%) have “not too much” or no trust in political information coming from the news media. While 66% of Democrats trust the news media, only 26% of Independents and 23% of Republicans do so. Other notable findings A slim majority of Americans say vaccines should be mandated at the federal (36%) or state level (16%). More than one in three people (36%) oppose mandates at either level. Significantly more Republicans (57%) than Democrats (15%) or Independents (42%) oppose mandatory vaccinations. When it comes to financing political campaigns, 71% find self-funded campaigns acceptable, 68% approve of contributions from individual citizens and 53% approve of PAC contributions. Further down the list of choices are super PACs (39%) and using federal tax dollars (34%). Visit our website to view the full Public Affairs Pulse survey results: pac.org/pulse About the Public Affairs Council Both nonpartisan and nonpolitical, the Public Affairs Council is the leading global association for public affairs professionals. The Council’s mission is to advance the field of public affairs and to provide its 700 member companies, nonprofits and universities with the executive education and expertise they need while maintaining the highest ethical standards. Learn more at pac.org. Contact Details Curley Company for the Public Affairs Council Lydia Niles +1 773-677-5327 lydia@curleycompany.com Company Website https://pac.org/

October 05, 2021 09:00 AM Eastern Daylight Time

1 ... 185 186 187 188 189 ... 227